213 related articles for article (PubMed ID: 35675366)
1. Comprehensive analysis of the importance of PLAUR in the progression and immune microenvironment of renal clear cell carcinoma.
Wang Z; Wang K; Gao X; Liu Z; Xing Z
PLoS One; 2022; 17(6):e0269595. PubMed ID: 35675366
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen Activator Urokinase Receptor Implies Immunosuppressive Features and Acts as an Unfavorable Prognostic Biomarker in Glioma.
Zeng F; Li G; Liu X; Zhang K; Huang H; Jiang T; Zhang Y
Oncologist; 2021 Aug; 26(8):e1460-e1469. PubMed ID: 33687124
[TBL] [Abstract][Full Text] [Related]
3. HJURP is a prognostic biomarker for clear cell renal cell carcinoma and is linked to immune infiltration.
Zhang F; Yuan D; Song J; Chen W; Wang W; Zhu G; Hu B; Chen X; Zhu J
Int Immunopharmacol; 2021 Oct; 99():107899. PubMed ID: 34217993
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
5. Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
Yoon JY; Gedye C; Paterson J; Ailles L
BMC Cancer; 2020 Apr; 20(1):272. PubMed ID: 32245446
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of
Wang T; Xie F; Li YH; Liang B
Future Oncol; 2021 Dec; 17(36):5033-5044. PubMed ID: 34704468
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC).
Liu S; Li S; Wang Y; Wang F; Zhang L; Xian S; Yang D; Yuan M; Dai F; Zhao X; Liu Y; Jin Y; Zeng Z; Mahgoub OKA; Zhou C; Cheng Y
J Cell Biochem; 2020 Mar; 121(3):2571-2581. PubMed ID: 31823423
[TBL] [Abstract][Full Text] [Related]
8. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
9. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
[TBL] [Abstract][Full Text] [Related]
10. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
[TBL] [Abstract][Full Text] [Related]
11. ENO2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract][Full Text] [Related]
12. SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics.
Xu K; Wu Y; Chi H; Li Y; She Y; Yin X; Liu X; He B; Li X; Du H
Medicine (Baltimore); 2022 Sep; 101(37):e30270. PubMed ID: 36123895
[TBL] [Abstract][Full Text] [Related]
13. LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment.
Dong X; Gu DN; Wang O; Ye Z
Int Immunopharmacol; 2020 Oct; 87():106793. PubMed ID: 32683301
[TBL] [Abstract][Full Text] [Related]
14. DDX39 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with clear cell renal cell carcinoma.
Bao Y; Jiang A; Dong K; Gan X; Gong W; Wu Z; Liu B; Bao Y; Wang J; Wang L
Int J Biol Sci; 2021; 17(12):3158-3172. PubMed ID: 34421357
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive landscape of immune-checkpoints uncovered in clear cell renal cell carcinoma reveals new and emerging therapeutic targets.
Tronik-Le Roux D; Sautreuil M; Bentriou M; Vérine J; Palma MB; Daouya M; Bouhidel F; Lemler S; LeMaoult J; Desgrandchamps F; Cournède PH; Carosella ED
Cancer Immunol Immunother; 2020 Jul; 69(7):1237-1252. PubMed ID: 32166404
[TBL] [Abstract][Full Text] [Related]
16. STEAP3 can predict the prognosis and shape the tumor microenvironment of clear cell renal cell carcinoma.
Wu J; Bi Q; Zheng X; Cao H; Hao C; Sun Z; Wang W
BMC Cancer; 2022 Nov; 22(1):1204. PubMed ID: 36424540
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
[TBL] [Abstract][Full Text] [Related]
18. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
[TBL] [Abstract][Full Text] [Related]
19. Construction of an immune-related prognostic model by exploring the tumor microenvironment of clear cell renal cell carcinoma.
He J; Zhong Y; Sun Y; Xie C; Yu T
Anal Biochem; 2022 Apr; 643():114567. PubMed ID: 35122734
[TBL] [Abstract][Full Text] [Related]
20. Large-scale transcriptome profiles reveal robust 20-signatures metabolic prediction models and novel role of G6PC in clear cell renal cell carcinoma.
Xu WH; Xu Y; Tian X; Anwaier A; Liu WR; Wang J; Zhu WK; Cao DL; Wang HK; Shi GH; Qu YY; Zhang HL; Ye DW
J Cell Mol Med; 2020 Aug; 24(16):9012-9027. PubMed ID: 32567187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
